Related references
Note: Only part of the references are listed.Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell
D. W. Cui et al.
TUMOR BIOLOGY (2014)
CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance
G. G. Sun et al.
TUMOR BIOLOGY (2014)
Decreased expression of CCNG2 is significantly linked to the malignant transformation of gastric carcinoma
G. G. Sun et al.
TUMOR BIOLOGY (2014)
Change in expression of cyclin G2 in kidney cancer cell and its significance
D. W. Cui et al.
TUMOR BIOLOGY (2014)
Changes in the expression of cyclin G2 in esophageal cancer cell and its significance
J. Q. Chen et al.
TUMOR BIOLOGY (2014)
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
Y. Iwagami et al.
BRITISH JOURNAL OF CANCER (2013)
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
N. Takeshita et al.
BRITISH JOURNAL OF CANCER (2013)
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
Marco Montagner et al.
NATURE (2012)
Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine
ZhenYu Zhao et al.
BRAIN RESEARCH BULLETIN (2011)
Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
Enza Lonardo et al.
CELL STEM CELL (2011)
Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
Erika Pastrana et al.
CELL STEM CELL (2011)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Xing J. Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Changes in Expression of Cell-Cycle-Related Genes in PC-3 Prostate Cancer Cells Caused by Ovine Uterine Serpin
Maria B. Padua et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Expression Levels of Cyclin G2, But Not Cyclin E, Correlate With Gastric Cancer Progression
Min-Gew Choi et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2
Takashi Kasukabe et al.
CANCER SCIENCE (2008)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Share Paper
